We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$18.7B
AUM Growth
+$1.36B
Cap. Flow
+$221M
Cap. Flow %
1.18%
Top 10 Hldgs %
25.29%
Holding
1,658
New
94
Increased
608
Reduced
275
Closed
90

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$68M
2
LIN icon
Linde
LIN
+$61M
3
EW icon
Edwards Lifesciences
EW
+$55.5M
4
IDXX icon
Idexx Laboratories
IDXX
+$46.4M
5
ARRY icon
Array Technologies
ARRY
+$45.8M

Sector Composition

Rank Sector Weight
1 Technology 30.65%
2 Healthcare 21.65%
3 Industrials 10.6%
4 Consumer Discretionary 9.49%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGS icon
1126
Progress Software
PRGS
$1.83B
$448K ﹤0.01%
7,716
JWN
1127
DELISTED
Nordstrom
JWN
$447K ﹤0.01%
21,830
-5,900
-21% -$99.2K
WD icon
1128
Walker & Dunlop
WD
$1.47B
$447K ﹤0.01%
5,651
AXSM icon
1129
Axsome Therapeutics
AXSM
$11.2B
$446K ﹤0.01%
6,200
+600
+11% +$44.3K
GNW icon
1130
Genworth Financial
GNW
$3.77B
$446K ﹤0.01%
89,290
URBN icon
1131
Urban Outfitters
URBN
$6.53B
$446K ﹤0.01%
13,453
PDCO
1132
DELISTED
Patterson Companies, Inc.
PDCO
$446K ﹤0.01%
13,400
NUVA
1133
DELISTED
NuVasive, Inc.
NUVA
$446K ﹤0.01%
10,716
BNL icon
1134
Broadstone Net Lease
BNL
$4.35B
$445K ﹤0.01%
28,800
+8,700
+43% +$139K
AKRO
1135
DELISTED
Akero Therapeutics
AKRO
$444K ﹤0.01%
9,500
+2,600
+38% +$119K
NGVT icon
1136
Ingevity
NGVT
$2.59B
$444K ﹤0.01%
7,637
CVNA icon
1137
Carvana
CVNA
$81B
$443K ﹤0.01%
85,500
+6,000
+8% +$16.6K
FORM icon
1138
FormFactor
FORM
$10.3B
$443K ﹤0.01%
12,960
WGO icon
1139
Winnebago Industries
WGO
$921M
$443K ﹤0.01%
6,644
ABR icon
1140
Arbor Realty Trust
ABR
$981M
$442K ﹤0.01%
29,800
AFRM icon
1141
Affirm
AFRM
$26.2B
$440K ﹤0.01%
+28,700
New +$381K
LGIH icon
1142
LGI Homes
LGIH
$1.37B
$440K ﹤0.01%
3,265
XPEL icon
1143
XPEL
XPEL
$1.39B
$440K ﹤0.01%
5,222
-300
-5% -$22.2K
ASB icon
1144
Associated Banc-Corp
ASB
$6.07B
$438K ﹤0.01%
26,962
CRI icon
1145
Carter's
CRI
$1.44B
$438K ﹤0.01%
6,030
PGTI
1146
DELISTED
PGT, Inc.
PGTI
$437K ﹤0.01%
15,000
+3,000
+25% +$79K
NARI
1147
DELISTED
Inari Medical, Inc. Common Stock
NARI
$436K ﹤0.01%
7,500
+400
+6% +$25.2K
KW
1148
DELISTED
Kennedy-Wilson Holdings
KW
$434K ﹤0.01%
26,576
PRFT
1149
DELISTED
Perficient Inc
PRFT
$434K ﹤0.01%
5,212
OSIS icon
1150
OSI Systems
OSIS
$3.77B
$432K ﹤0.01%
3,665

Similar funds

Handelsbanken Fonder's Q2 2023 Portfolio in Review

As of Q2 2023, Handelsbanken Fonder held 1,658 positions worth $18.7B, up 7.9% from $17.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Handelsbanken Fonder's Q2 2023 filing shows 94 new, 608 increased, 275 reduced and 90 closed positions. Its largest new stake was Linde: 166,967 shares worth $63.6M. The largest sale was Berkshire Hathaway Class B, an estimated $98.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Handelsbanken Fonder's largest Q2 2023 buy was Linde: 166,967 shares worth $63.6M.
  • Handelsbanken Fonder added most to Microsoft in Q2 2023, an estimated $68M increase.
  • Handelsbanken Fonder's biggest Q2 2023 reduction was Alibaba, cutting an estimated $83.5M.
  • Handelsbanken Fonder fully exited Berkshire Hathaway Class B in Q2 2023, selling an estimated $98.4M.
  • Handelsbanken Fonder's ten largest holdings make up 25% of its $18.7B portfolio in Q2 2023.
  • Handelsbanken Fonder opened 94 new positions and closed 90 in Q2 2023.
  • Handelsbanken Fonder's portfolio value rose 7.9% quarter-over-quarter to $18.7B.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.